Marie-Kristin Tilch

University Medical Center of the Johannes Gutenberg University, Mainz

Department of Internal Medicine III
Paul-Ehrlich Weg
55118 Mainz


Tilch MK, Galle PR, Schattenberg JM, Kostev K, Labenz C. Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany. Support Care Cancer. 2022 Mar;30(3):2387-2395. doi: 10.1007/s00520-021-06677-w. Epub 2021 Nov 10. PMID: 34761297; PMCID: PMC8795002.


Tilch MK, Robak T, Ghiggi C, Wuff E, Herold S, Theobald M, Hess G. Safety of the Anti-CD19 antibody Tafasitamab in Long Term Responders from A Phase II Trial for Relapsed Lymphoma. Clin Lymphoma Myeloma Leuk. 2021 Oct 16:S2152-2650(21)02382-X. doi: 10.1016/j.clml.2021.10.005. Epub ahead of print. PMID: 34776401.


Schwaegermann MK, Hobohm L, Rausch J, Reuter M, Griemert TF, Sivanathan V, Falter T, Sprinzl MF, Lackner KJ, Galle PR, Konstantinides S, Theobald M, von Auer C. COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report. Hamostaseologie. 2021 Jul 29. doi: 10.1055/a-1497-1054. Epub ahead of print. PMID: 34327693.


Schwaegermann MK, Schranz M, Moehler M, Labenz C, Moringlane A, Schmidt M, Theobald M, Hess G. Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center. J Cancer Res Clin Oncol. 2021 Jan 9. doi: 10.1007/s00432-020-03495-1. Epub ahead of print. PMID: 33420813.